You can enrol in up to 20 courses during temporary access. You’ve reached this limit and can’t enrol in any more right now.
Once you have full access, you’ll be able to enrol without limit.
Ms. D was a 30-year-old married woman with 2 children; pregnant with her third child.
Ms. D has a medical history of ulcerative pancolitis, leading to diarrhoea (sometimes with bloody stools), malabsorption, weight loss, a reduced appetite and fatigue. Her pre-pregnancy weight was 46 kg and on referral her weight was 48.5 kg, giving her a BMI of 16.2 kg/m2. Her first 2 children were small for gestational age.
Ms. D was referred to the Maternity Dietetic Services Manager by the local Community Dietitian, who had already advised the patient to follow a low residue diet and take a polymeric oral nutritional supplement (ONS), which Ms. D had been prescribed in previous pregnancies.
On initial assessment, Ms. D’s ONS prescription was changed from a polymeric ONS formula to Vital 1.5kcal, a peptide-based oral nutritional supplement, rich in medium-chain triglycerides. Four weeks later, Ms. D had gained 5.1 kg, reaching 53.6 kg at 22 weeks. Foetal weight gain was excellent. Ms D’s weight continued to increase throughout pregnancy and at final follow up at 38 weeks of gestation, Ms. D weighed 64.5 kg, having experienced a total pregnancy weight gain of 16.9 kg.
2 x 200 ml bottles Vital 1.5kcal daily – to take as needed as dietary intake was erratic and varied daily.
Ms. D experienced good weight gain during her pregnancy of 16.9 kg, which is in line with recommendations. There was some improvement in diarrhoea and taking an ONS also seemed to improve her appetite. Baby also had excellent weight gain and growth.
Ms. D said, ‘Vital 1.5kcal is the only ONS drink I have been able to tolerate. During my pregnancy this time, my appetite was better and I had more energy compared to when I took other ONS drinks in my previous pregnancies’.
Small for gestational age babies are more likely to experience poor health outcomes in later life, impacting NHS costs. In this case, baby was born at a good weight, being on the 80th centile for weight. He was not small for gestational age, unlike Ms. D’s first two children.
Sue is a 42 year old female patient with a subtotal colectomy and ileostomy.
![]()
Sue is a 42 year old female patient with a subtotal colectomy and ileostomy. She was admitted to hospital with chronic diarrhoea, and investigation showed evidence of ulceration of the ileosigmoid anastamosis and terminal ileum. During this admission she had numerous medical interventions such as steroid therapy, blood and ferritin transfusions, diuretics and a trial of Creon. She was fed via nasogastric (NG) feeding tube as she was only consuming half of her meals. Previously she had unsuccessfully trialled various whole protein oral nutritional supplements (ONS) and modular supplements, which she had felt exacerbated the diarrhoea.
Rupert is a 65 year old male with Ménière’s disease, chronic obstructive pulmonary disease (COPD), depression, angina and previous history of transient ischaemic attacks (TIAs).
![]()
Rupert is a 65 year old male with Ménière’s disease, chronic obstructive pulmonary disease (COPD), depression, angina and previous history of transient ischaemic attacks (TIAs). Rupert was admitted to hospital with gastroenteritis and poorly controlled angina. He develop loose stools (type 7 on the Bristol Stool Chart) which persisted for four weeks and Metronidazole was prescribed for suspected C.difficile. His loose watery stools persisted and after a flexible sigmoidoscopy and colonoscopy were performed, Rupert was diagnosed with non-infective gastroenteritis and colitis. Codeine phosphate, Citalopram, Omeprazole, Prednisolone were trialled during this time. Rupert was only managing to consume a quarter of his meals and was prescribed whole protein oral nutritional supplements (ONS).
Phil is a 64 year old male undergoing palliative chemotherapy for pancreatic cancer and had a biliary stent in situ.
![]()
Phil is a 64 year old male undergoing palliative chemotherapy for pancreatic cancer and had a biliary stent in situ. He was consuming all of his meals but required additional supplementation to meet his nutritional requirements. Whole protein oral nutritional supplements (ONS) were not tolerated as they exacerbated his diarrhoea.
UK-N/A-2300294 | November 2023
SESSION TIMEOUT
Please log in to continue
Thanks for registering. To begin, please log in to your ProConnect account. After you log in, you’ll have temporary access to all resources and education while we verify your details.
Added to Bag
ENSURE PLUS
1 x 220 ml
Flavor: Apple
1,5 kcal / ml
Nutrition Information
| Unit | Per {ml-col-1} ml | Per {ml-col-2} ml |
| Unit | Per {ml-col-1} ml | Per {ml-col-2} ml |
| Unit | Per {ml-col-1} ml | Per {ml-col-2} ml |
footnotes
Product details not available.
You have {liteUserDaysLeft} business days of temporary access.
Based on your email address {email} your account has not yet been approved. We’re validating your credentials. You won’t be able to order samples until your account is approved and activated. Please check your email for more details. For help, contact us at abbott.proconnect_access@nhs.net.
UK--2500192 | September 2025
You have {liteUserDaysLeft} business days of temporary access.
Based on your email address {email} your credentials are validated but not yet activated. To gain full access, including the ability to order samples, click the activation link we sent to your inbox. For help, contact us at abbott.proconnect_access@nhs.net.
UK--2500192 | September 2025
Register to continue reading this article
UK-N/A-2400058(v9) | September 2025
You are about to exit for another Abbott country or region specific website.
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimised for your specific screen size.
Do you wish to continue and exit this website?
UK-N/A-2200465 | July 2022
This website is for UK HCPs and UK Patients only. If you are outside of the UK please visit our global website Abbott.com
If you choose "I am a patient/carer”, you will be entering a website intended for patients and carers which has information on Abbott products. Products on this website are to be used under medical supervision. If you have questions about the product information discussed on this website, you should consult with your healthcare professional.